Additional Metadata
Persistent URL dx.doi.org/10.1177/1352458520921367, hdl.handle.net/1765/127220
Journal Multiple Sclerosis: clinical and laboratory research
Citation
Bruijstens, A.L. (Arlette L), Blok, K.M. (Katelijn M), Smolders, J. (Joost), Wokke, B.H.A. (Beatrijs HA), & Neuteboom, R.F. (2020). Pediatric MS patients with a primary progressive-like disease may still have relevant inflammatory activity and may benefit from regular MS treatment. Multiple Sclerosis: clinical and laboratory research. doi:10.1177/1352458520921367